Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  glutamine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-13 of 13 for your search:
Start Over
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: GLU_07, NCT00772824
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 170/11, NCT01552291
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0309006308, NCT00195013
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2013-0308, NCI-2014-00917, NCT01952847
The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 20 to 65
Sponsor: Other
Protocol IDs: 031, NCT02024191
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Phase: Phase III
Type: Supportive care
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: TCVGH-1047004C, NCT02282839
Use of ß-hydroxy-ß-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 00016781, NCT01607879
Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 202253, NCT02012608
Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UVaHS-144404, NCT02053350
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ERMC 13-32, NCT02215083
Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EC1432-00, HARECCTR0500034, NCT00563498
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: AIRCo05.02.2009/2, NCT00922688
Prospective Study of the Effect of Perioperative Immunonutrition on the Immune Host Defense and the Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3-37878 L, NCT01704664
Start Over